BioCardia, Inc. (BCDA) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Biocardia, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.236 Participants of this call are advised that the audio of this conference call 00:00:05.236 -- 00:00:10.381 is being broadcast live over the internet and is also being recorded for playback 00:00:10.381 -- 00:00:15.445 purposes. A webcast replay of the call will be available approximately 00:00:15.445 -- 00:00:20.750 one hour after the end of the call. I would now like to turn the call 00:00:20.750 -- 00:00:22.993 over to Miranda 00:00:22.993 -- 00:00:29.317 Pato of BioCardia Investor Relations. Please go ahead, Miranda. 00:00:31.182 -- 00:00:36.367 Thank you, Dave. Good afternoon, and thank you for participating in today's conference 00:00:36.367 -- 00:00:41.772 call. Joining me from BioCardio's leadership team are Peter Altman, 00:00:41.772 -- 00:00:47.076 President and Chief Executive Officer, and David McClung, the company's 00:00:47.076 -- 00:00:52.061 Chief Financial Officer. During this call, management will be making forward-looking 00:00:52.061 -- 00:00:57.246 statements, including statements that address BioCardio's expectations 00:00:57.246 -- 00:01:03.150 for future performance and operational results, references to management's intentions, 00:01:03.150 -- 00:01:08.738 beliefs, projections, book analyses, and current expectations. 00:01:08.738 -- 00:01:13.924 Such factors include, among others, the inherent uncertainties associated 00:01:13.924 -- 00:01:20.092 with developing new products, technologies, and obtaining regulatory approvals. 00:01:20.092 -- 00:01:25.479 Forward-looking statements involve risks and other factors that may cause actual results 00:01:25.479 -- 00:01:28.463 to differ materially from those statements. 00:01:28.463 -- 00:01:33.379 For more information about these risks, Please refer to the risk fac...